In the context of tumor angiogenesis, DJ-1 has been identified as a key secreted factor that promotes FGFR1 activation in endothelial cells by enhancing phosphorylation at these residues, thereby contributing to sorafenib resistance in hepatocellular carcinoma (HCC) [176]. This evidence concerns the gene PARK7 and hepatocellular carcinoma.